1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
ACADEMIA
Univ. Says Data Leaks in SIGN Run Afoul of Personal Information Law, Newly Finds Bristol’s Misconduct
The University of Tokyo says that its staff members committed “gross negligence” that constitutes a violation of a Japanese law in allowing the leak of patient data in a clinical trial involving Tasigna (nilotinib), Novartis Pharma’s chronic myeloid leukemia (CML)…
To read the full story
Related Article
- Bristol’s Involvement in Sprycel Trial Could Contravene Ethics Code, but Not PAL: Probe
October 28, 2014
- BMKK Asks Major Law Firm to Conduct Independent Investigation of Clinical Research on Sprycel
July 4, 2014
- BMKK to Begin Third-Party Investigation into Company Involvement in Sprycel Trial
June 26, 2014
- University of Tokyo Admits Inappropriate Patient Data Corrections in J-ADNI
June 25, 2014
- Univ. Says Data Leaks in SIGN Run Afoul of Personal Information Law, Newly Finds Bristol’s Misconduct
June 25, 2014
- Novartis Workers were Acting for Office of SIGN Trial Initiator Group: University of Tokyo
March 17, 2014
- University of Tokyo Admits Patient Information on SIGN Trial Leaked to Novartis
March 17, 2014
ACADEMIA
- Oncologist Sees Need to Seek Middle Ground towards CGP Testing for 1st Line Therapy
February 17, 2025
- Lingering Shortage of Fentanyl Affecting Medical Practices: Pharmacist
February 13, 2025
- Medical Society Says “No” to Discontinuation of Theodur Despite Supply Struggle
February 5, 2025
- Refusal to See Patients due to Kostaive Shots Might Violate “Duty of Care”: Lawyer
December 17, 2024
- Generic DPP-4s to Impact Diabetes Care and Health Finances, Potential Shortages a Concern
December 6, 2024
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…